SEARCH NEWS & VIEWS


Philanthropist Samuel Yin Provides $12.8 Million Gift for New Scripps California Laboratories
Remicade® Developer Funds New Super-Resolution Microscope at Scripps Florida
Crouching Protein, Hidden Enzyme
NEWS & VIEWS HOME
PAST ISSUES
KUDOS
SCIENTIFIC CALENDAR
CA AUDITORIUM EVENTS
CONTACT

FOLLOW US

Of Note


Disney Lab ALS Study Selected for Best of Neuron

A study led by Matthew Disney, professor at The Scripps Research Institute (TSRI), and Professor Leonard Petrucelli of the Mayo Clinic has been included in Best of Neuron, 2014-2015, a collection of the readers’ and editors’ favorites celebrating the research published in the journal Neuron. 

The study, "Discovery of a Biomarker and Lead Small Molecules to Target r(GGGGCC)-Associated Defects in c9FTD/ALS," described a therapeutic strategy targeting a specific genetic mutation that causes a common form of amyotrophic lateral sclerosis (ALS, a.k.a. Lou Gehrig’s disease), as well a type of frontotemporal dementia. 

For additional information, see the August 2014 paper in Neuron, the News&Views article on the research or Best of Neuron, 2014-2015. For more on Disney’s research, visit his faculty website and lab website .





Send comments to: mikaono[at]scripps.edu

disney
A study by co-led by TSRI Professor Matthew Disney is among Neuron readers’ and editors’ favorites. (Photo by James McEntee.)